Europe Dermal Substitute Market Insights, Forecast to 2027

Europe Dermal Substitute Market Insights, Forecast to 2027

Table of Contents
1 STUDY COVERAGE 1
1.1 Dermal Substitute Product Introduction 1
1.2 Market by Type 1
1.2.1 Europe Dermal Substitute Market Size Growth Rate by Type 1
1.2.2 Synthetic Materials 3
1.2.3 Biological Materials 4
1.3 Market by Application 5
1.3.1 Europe Dermal Substitute Market Size Growth Rate by Application 5
1.3.2 Chronic Wounds 7
1.3.3 Post Cancer Skin Defects 7
1.3.4 Burns 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Europe Dermal Substitute Sales Estimates and Forecasts 2016-2027 10
2.2 Europe Dermal Substitute Revenue Estimates and Forecasts 2016-2027 10
2.3 Europe Dermal Substitute Revenue by Country: 2016 VS 2021 VS 2027 11
2.4 Europe Top Dermal Substitute Country by Sales 13
2.4.1 Europe Top Dermal Substitute Country by Sales (2016-2021) 13
2.4.2 Europe Top Dermal Substitute Country by Sales (2022-2027) 14
2.5 Europe Top Dermal Substitute Country by Revenue 15
2.5.1 Europe Top Dermal Substitute Country by Revenue (2016-2021) 15
2.5.2 Europe Top Dermal Substitute Country by Revenue (2022-2027) 16
2.6 Germany 17
2.7 France 18
2.8 U.K. 19
2.9 Italy 20
2.10 Spain 21
3 COMPETITION BY MANUFACTURERS 22
3.1 Europe Dermal Substitute Sales by Manufacturers 22
3.1.1 Europe Top Dermal Substitute Manufacturers by Sales (2016-2021) 22
3.1.2 Europe Top Dermal Substitute Manufacturers Market Share by Sales (2016-2021) 23
3.1.3 Europe Top 6 and Top 3 Companies by Dermal Substitute Sales in 2020 23
3.2 Europe Dermal Substitute Revenue by Manufacturers 24
3.2.1 Europe Top Dermal Substitute Manufacturers by Revenue (2016-2021) 24
3.2.2 Europe Top Dermal Substitute Manufacturers Market Share by Revenue (2016-2021) 25
3.2.3 Europe Top 6 and Top 3 Companies by Dermal Substitute Revenue in 2020 26
3.3 Europe Dermal Substitute Sales Price by Manufacturers 26
3.4 Analysis of Competitive Landscape 27
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 27
3.4.2 Europe Dermal Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 28
3.4.3 Europe Dermal Substitute Manufacturers Geographical Distribution 29
3.5 Mergers & Acquisitions, Expansion Plans 31
3.6 Germany Players List 31
3.7 France Players List 32
3.8 U.K. Players List 32
3.9 Italy Players List 33
3.10 Spain Players List 33
4 MARKET SIZE BY TYPE 34
4.1 Europe Dermal Substitute Sales by Type 34
4.1.1 Europe Dermal Substitute Historical Sales by Type (2016-2021) 34
4.1.2 Europe Dermal Substitute Forecasted Sales by Type (2022-2027) 34
4.1.3 Europe Dermal Substitute Sales Market Share by Type (2016-2027) 34
4.2 Europe Dermal Substitute Revenue by Type 35
4.2.1 Europe Dermal Substitute Historical Revenue by Type (2016-2021) 35
4.2.2 Europe Dermal Substitute Forecasted Revenue by Type (2022-2027) 35
4.2.3 Europe Dermal Substitute Revenue Market Share by Type (2016-2027) 36
4.3 Europe Dermal Substitute Price by Type 36
4.3.1 Europe Dermal Substitute Price by Type (2016-2021) 36
4.3.2 Europe Dermal Substitute Price Forecast by Type (2022-2027) 37
5 MARKET SIZE BY APPLICATION 38
5.1 Europe Dermal Substitute Sales by Application 38
5.1.1 Europe Dermal Substitute Historical Sales by Application (2016-2021) 38
5.1.2 Europe Dermal Substitute Forecasted Sales by Application (2022-2027) 38
5.1.3 Europe Dermal Substitute Sales Market Share by Application (2016-2027) 38
5.2 Europe Dermal Substitute Revenue by Application 39
5.2.1 Europe Dermal Substitute Historical Revenue by Application (2016-2021) 39
5.2.2 Europe Dermal Substitute Forecasted Revenue by Application (2022-2027) 40
5.2.3 Europe Dermal Substitute Revenue Market Share by Application (2016-2027) 40
5.3 Europe Dermal Substitute Price by Application 41
5.3.1 Europe Dermal Substitute Price by Application (2016-2021) 41
5.3.2 Europe Dermal Substitute Price Forecast by Application (2022-2027) 41
6 CORPORATE PROFILE 43
6.1 Integra LifeSciences 43
6.1.1 Integra LifeSciences Corporation Information 43
6.1.2 Integra LifeSciences Overview 43
6.1.3 Integra LifeSciences in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 44
6.1.4 Integra LifeSciences Dermal Substitute Product Description 44
6.1.5 Integra LifeSciences Recent Developments 45
6.2 Gunze Medical 45
6.2.1 Gunze Medical Corporation Information 45
6.2.2 Gunze Medical Overview 45
6.2.3 Gunze Medical in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 46
6.2.4 Gunze Medical Dermal Substitute Product Description 46
6.2.5 Gunze Medical Recent Developments 46
6.3 Medskin Suwelack 47
6.3.1 Medskin Suwelack Corporation Information 47
6.3.2 Medskin Suwelack Overview 47
6.3.3 Medskin Suwelack in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 47
6.3.4 Medskin Suwelack Dermal Substitute Product Description 48
6.4 Anika Therapeutics 50
6.4.1 Anika Therapeutics Corporation Information 50
6.4.2 Anika Therapeutics Overview 50
6.4.3 Anika Therapeutics in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 51
6.4.4 Anika Therapeutics Dermal Substitute Product Description 51
6.4.5 Anika Therapeutics Recent Developments 51
6.5 Symatese Group 52
6.5.1 Symatese Group Corporation Information 52
6.5.2 Symatese Group Overview 52
6.5.3 Symatese Group in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 52
6.5.4 Symatese Group Dermal Substitute Product Description 53
6.5.5 Symatese Group Recent Developments 54
6.6 Smith & Nephew 54
6.6.1 Smith & Nephew Corporation Information 54
6.6.2 Smith & Nephew Overview 55
6.6.3 Smith & Nephew in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 55
6.6.4 Smith & Nephew Dermal Substitute Product Description 55
6.6.5 Smith & Nephew Recent Developments 56
6.7 Allergan 56
6.7.1 Allergan Corporation Information 56
6.7.2 Allergan Overview 56
6.7.3 Allergan in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 57
6.7.4 Allergan Dermal Substitute Product Description 57
6.7.5 Allergan Recent Developments 57
6.8 Tissue Regenix 58
6.8.1 Tissue Regenix Corporation Information 58
6.8.2 Tissue Regenix Overview 58
6.8.3 Tissue Regenix in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 59
6.8.4 Tissue Regenix Dermal Substitute Product Description 59
6.9 Organogenesis 59
6.9.1 Organogenesis Corporation Information 59
6.9.2 Organogenesis Overview 60
6.9.3 Organogenesis in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 60
6.9.4 Organogenesis Dermal Substitute Product Description 60
6.10 Mylan 62
6.10.1 Mylan Corporation Information 62
6.10.2 Mylan Overview 62
6.10.3 Mylan in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 62
6.10.4 Mylan Dermal Substitute Product Description 63
6.10.5 Mylan Recent Developments 63
6.11 Medtronic 64
6.11.1 Medtronic Corporation Information 64
6.11.2 Medtronic Overview 64
6.11.3 Medtronic in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 65
6.11.4 Medtronic Dermal Substitute Product Description 66
6.12 MiMedx 66
6.12.1 MiMedx Corporation Information 66
6.12.2 MiMedx Overview 67
6.12.3 MiMedx in Europe: Dermal Substitute Sales, Price, Revenue and Gross Margin (2016-2021) 67
6.12.4 MiMedx Dermal Substitute Product Description 67
6.12.5 MiMedx Recent Developments 68
7 VALUE CHAIN AND SALES CHANNELS ANALYSIS 69
7.1 Dermal Substitute Value Chain Analysis 69
7.2 Dermal Substitute Key Raw Materials 70
7.2.1 Key Raw Materials 70
7.2.2 Raw Materials Key Suppliers 70
7.3 Dermal Substitute Sales and Marketing 71
7.3.1 Dermal Substitute Sales Channels 71
7.3.2 Dermal Substitute Distributors 72
7.4 Dermal Substitute Customers 74
8 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 75
8.1 Dermal Substitute Industry Trends 75
8.2 Dermal Substitute Market Drivers 75
8.3 Dermal Substitute Market Challenges 76
8.4 Dermal Substitute Market Restraints 76
9 KEY FINDINGS IN THE EUROPE DERMAL SUBSTITUTE STUDY 77
10 APPENDIX 78
10.1 Research Methodology 78
10.1.1 Methodology/Research Approach 78
10.1.2 Data Source 81
10.2 Author Details 83
10.3 Disclaimer 84
List of Tables
Table 1. Europe Dermal Substitute Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) 2
Table 2. Major Manufacturers of Biological Materials 5
Table 3. Europe Dermal Substitute Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) 5
Table 4. Europe Dermal Substitute Revenue by Country: 2016 VS 2021 VS 2027 (US$ Million) 11
Table 5. Europe Dermal Substitute Sales by Country (2016-2021) & (K Units) 13
Table 6. Europe Dermal Substitute Sales Market Share by Country (2016-2021) 13
Table 7. Europe Dermal Substitute Sales Market Share by Country in 2020 14
Table 8. Europe Dermal Substitute Sales by Country (2022-2027) & (K Units) 14
Table 9. Europe Dermal Substitute Sales Market Share by Country (2022-2027) 14
Table 10. Europe Dermal Substitute Sales Market Share by Country (2022-2027) 15
Table 11. Europe Dermal Substitute Revenue by Country (2016-2021) & (US$ Million) 15
Table 12. Europe Dermal Substitute Revenue Market Share by Country (2016-2021) 16
Table 13. Europe Dermal Substitute Revenue by Country (2022-2027) & (US$ Million) 16
Table 14. Europe Dermal Substitute Revenue Market Share by Country (2022-2027) 16
Table 15. Europe Dermal Substitute Sales by Manufacturers (2016-2021) & (K Units) 22
Table 16. Europe Dermal Substitute Sales Share by Manufacturers (2016-2021) 23
Table 17. Europe Dermal Substitute Revenue by Manufacturers (2016-2021) & (US$ Million) 24
Table 18. Europe Dermal Substitute Revenue Share by Manufacturers (2016-2021) 25
Table 19. Dermal Substitute Price by Manufacturers 2016-2021 (USD/Unit) 27
Table 20. Europe Dermal Substitute Manufacturers Market Concentration Ratio (CR5 and HHI) 27
Table 21. Europe Dermal Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Substitute as of 2020) 28
Table 22. Dermal Substitute Manufacturing Base Distribution and Headquarters 29
Table 23. Manufacturers Dermal Substitute Product Offered 30
Table 24. Date of Establishment 30
Table 25. Mergers & Acquisitions, Expansion Plans 31
Table 26. Germany Players List 31
Table 27. France Players List 32
Table 28. U.K. Players List 32
Table 29. Italy Players List 33
Table 30. Spain Players List 33
Table 31. Europe Dermal Substitute Sales by Type (2016-2021) & (K Units) 34
Table 32. Europe Dermal Substitute Sales by Type (2022-2027) & (K Units) 34
Table 33. Europe Dermal Substitute Sales Share by Type (2016-2021) 34
Table 34. Europe Dermal Substitute Sales Share by Type (2022-2027) 34
Table 35. Europe Dermal Substitute Revenue by Type (2016-2021) & (US$ Million) 35
Table 36. Europe Dermal Substitute Revenue by Type (2022-2027) & (US$ Million) 35
Table 37. Europe Dermal Substitute Revenue Share by Type (2016-2021) 36
Table 38. Europe Dermal Substitute Revenue Share by Type (2022-2027) 36
Table 39. Dermal Substitute Price by Type (2016-2021) & (USD/Unit) 36
Table 40. Europe Dermal Substitute Price Forecast by Type (2022-2027) & (USD/Unit) 37
Table 41. Europe Dermal Substitute Sales by Application (2016-2021) & (K Units) 38
Table 42. Europe Dermal Substitute Sales by Application (2022-2027) & (K Units) 38
Table 43. Europe Dermal Substitute Sales Share by Application (2016-2021) 38
Table 44. Europe Dermal Substitute Sales Share by Application (2022-2027) 39
Table 45. Europe Dermal Substitute Revenue by Application (2016-2021) & (US$ Million) 39
Table 46. Europe Dermal Substitute Revenue by Application (2022-2027) & (US$ Million) 40
Table 47. Europe Dermal Substitute Revenue Share by Application (2016-2021) 40
Table 48. Europe Dermal Substitute Revenue Share by Application (2022-2027) 40
Table 49. Dermal Substitute Price by Application (2016-2021) & (USD/Unit) 41
Table 50. Europe Dermal Substitute Price Forecast by Application (2022-2027) & (USD/Unit) 41
Table 51. Integra LifeSciences Corporation Information 43
Table 52. Integra LifeSciences Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 44
Table 53. Integra LifeSciences Dermal Substitute Product 44
Table 54. Integra LifeSciences Recent Developments 45
Table 55. Gunze Medical Corporation Information 45
Table 56. Gunze Medical Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 46
Table 57. Gunze Medical Dermal Substitute Product 46
Table 58. Gunze Medical Recent Developments 46
Table 59. Medskin Suwelack Corporation Information 47
Table 60. Medskin Suwelack Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 47
Table 61. Medskin Suwelack Dermal Substitute Product 48
Table 62. Anika Therapeutics Corporation Information 50
Table 63. Anika Therapeutics Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 51
Table 64. Anika Therapeutics Dermal Substitute Product 51
Table 65. Anika Therapeutics Recent Developments 51
Table 66. Symatese Group Corporation Information 52
Table 67. Symatese Group Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 52
Table 68. Symatese Group Dermal Substitute Product 53
Table 69. Symatese Group Recent Developments 54
Table 70. Smith & Nephew Corporation Information 54
Table 71. Smith & Nephew Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 55
Table 72. Smith & Nephew Dermal Substitute Product 55
Table 73. Smith & Nephew Recent Developments 56
Table 74. Allergan Corporation Information 56
Table 75. Allergan Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 57
Table 76. Allergan Dermal Substitute Product 57
Table 77. Allergan Recent Developments 57
Table 78. Tissue Regenix Corporation Information 58
Table 79. Tissue Regenix Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 59
Table 80. Tissue Regenix Dermal Substitute Product 59
Table 81. Organogenesis Corporation Information 59
Table 82. Organogenesis Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 60
Table 83. Organogenesis Dermal Substitute Product 60
Table 84. Mylan Corporation Information 62
Table 85. Mylan Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 62
Table 86. Mylan Dermal Substitute Product 63
Table 87. Mylan Recent Developments 63
Table 88. Medtronic Corporation Information 64
Table 89. Medtronic Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 65
Table 90. Medtronic Dermal Substitute Product 66
Table 91. MiMedx Corporation Information 66
Table 92. MiMedx Dermal Substitute Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 67
Table 93. MiMedx Dermal Substitute Product 67
Table 94. MiMedx Recent Developments 68
Table 95. Key Raw Materials Lists 70
Table 96. Raw Materials Key Suppliers Lists 70
Table 97. Dermal Substitute Distributors List 72
Table 98. Dermal Substitute Customers List 74
Table 99. Dermal Substitute Market Trends 75
Table 100. Dermal Substitute Market Drivers 75
Table 101. Dermal Substitute Market Challenges 76
Table 102. Dermal Substitute Market Restraints 76
Table 103. Research Programs/Design for This Report 78
Table 104. Key Data Information from Secondary Sources 81
Table 105. Key Data Information from Primary Sources 82
List of Figures
Figure 1. Dermal Substitute Product Picture 1
Figure 2. Europe Dermal Substitute Market Share by Type in 2020 & 2027 2
Figure 3. Synthetic Materials Product Picture 4
Figure 4. Major Manufacturers of Synthetic Materials 4
Figure 5. Biological Materials Product Picture 5
Figure 6. Europe Dermal Substitute Market Share by Application in 2020 & 2027 6
Figure 7. Chronic Wounds 7
Figure 8. Post Cancer Skin Defects 7
Figure 9. Burns 8
Figure 10. Dermal Substitute Report Years Considered 9
Figure 11. Europe Dermal Substitute Sales 2016-2027 (K Units) 10
Figure 12. Europe Dermal Substitute Revenue, (US$ Million), 2016 VS 2021 VS 2027 11
Figure 13. Europe Dermal Substitute Revenue 2016-2027 (US$ Million) 11
Figure 14. Europe Dermal Substitute Revenue Market Share by Country in Percentage: 2020 Versus 2027 12
Figure 15. Germany Dermal Substitute Sales YoY (2016-2027) & (K Units) 17
Figure 16. Germany Dermal Substitute Revenue YoY (2016-2027) & (US$ Million) 17
Figure 17. France Dermal Substitute Sales YoY (2016-2027) & (K Units) 18
Figure 18. France Dermal Substitute Revenue YoY (2016-2027) & (US$ Million) 18
Figure 19. U.K. Dermal Substitute Sales YoY (2016-2027) & (K Units) 19
Figure 20. U.K. Dermal Substitute Revenue YoY (2016-2027) & (US$ Million) 19
Figure 21. Italy Dermal Substitute Sales YoY (2016-2027) & (K Units) 20
Figure 22. Italy Dermal Substitute Revenue YoY (2016-2027) & (US$ Million) 20
Figure 23. Spain Dermal Substitute Sales YoY (2016-2027) & (K Units) 21
Figure 24. Spain Dermal Substitute Revenue YoY (2016-2027) & (US$ Million) 21
Figure 25. The Top 6 and Top 3 Players Market Share by Dermal Substitute Sales in 2020 23
Figure 26. The Top 6 and Top 3 Players Market Share by Dermal Substitute Revenue in 2020 26
Figure 27. Dermal Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2020 29
Figure 28. Europe Dermal Substitute Sales Market Share by Type (2016-2027) 35
Figure 29. Europe Dermal Substitute Revenue Market Share by Type (2016-2027) 36
Figure 30. Europe Dermal Substitute Sales Market Share by Application (2016-2027) 39
Figure 31. Europe Dermal Substitute Revenue Market Share by Application (2016-2027) 41
Figure 32. Dermal Substitute Value Chain 69
Figure 33. Channels of Distribution 72
Figure 34. Distributors Profiles 73
Figure 35. Bottom-up and Top-down Approaches for This Report 80
Figure 36. Data Triangulation 81
Figure 37. Key Executives Interviewed 83

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs